Table 3 Follow-up cohort – divided by severity of clinical allergy at food challenge in original study
CANA (n = 9) | Anaphylaxis n = 5 | P value | ||
|---|---|---|---|---|
Age (years) | Median (min, max) | 10.9 (4.5, 17.8) | 16.0 (14.0, 17.4) | 0.029 |
Sex (%) | Males | 3 (33) | 4 (80) | 0.266 |
Parental smokers (%) | Total | 2 (22) | 0 (0) | 0.506 |
Previous adrenaline required (%) | Total | 1 (11) | 5 (100) | 0.003 |
Other food allergy (%) | Total | 4 (44) | 1 (20) | 0.580 |
AR (%) | Total | 5 (56) | 3 (30) | 1.000 |
AR severity for those with AR—max = 4a | Median (min, max) | 4 (2, 4) | 3 (1, 4) | 0.750 |
Eczema ever (%) | Total | 7 (78) | 3 (60) | 0.580 |
Eczema active treatment (%) | Total | 4 (44) | 1 (20) | 0.580 |
SCORAD for those with visible eczema | Median (min, max) | 7.4 (3.4, 24.4) | 0.0 (0.0, 0.0) | N/A |
Asthma ever (%) | Total | 5 (56) | 3 (60) | 1.000 |
Current preventer (%) | Total | 2 (22) | 1 (20) | 1.000 |
Current reliever (%) | Total | 5 (56) | 2 (40) | 1.000 |
Ara h2 SPT (mm) (min, max) | Median (min, max) | 7.0 (2.0, 8.0) | 5.0 (3.5, 9.0) | 0.541 |
Peanut SPT (mm) (min, max) | Median (min, max) | 8.0 (5.5, 12.5) | 6.0 (5.0, 13.0) | 0.968 |
Ara h2 sIgE (kU/L) | Median (min, max) | 1.15 (0.41, 14.50) | 5.02 (0.80, 22.10) | 0.227 |
Peanut sIgE (kU/L) | Median (min, max) | 1.49 (0.32, 23.30) | 3.88 (1.01, 21.80) | 0.240 |
FeNO (p.p.b)b | Median (min, max) | 28.3 (15.2, 119.2) | 55.1 (15.4, 79.5) | 0.631 |